hydrochlorothiazide has been researched along with penbutolol in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (57.14) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bravi, M; Broglia, M; Carisdeo, V; Giuffrè, G; Torriani, A | 1 |
| Arnau, C; Castellet, R; del Río, G; Ocón, J; Piña, C; Vila, R | 1 |
| del Río, G; Ocón, J; Piña, C | 1 |
| De Plaen, JF; Van Ypersele de Strihou, C; Vander Elst, E | 1 |
1 review(s) available for hydrochlorothiazide and penbutolol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for hydrochlorothiazide and penbutolol
| Article | Year |
|---|---|
[Clinical evaluation of penbutolol (Hoe, 893 d) (beta adrenergic blockader), alone and in combination with hydrochlorothiazide, in the treatment of arterial hypertension. I: Effect on arterial hypertension. Comparative study of 2 parallel groups with cros
Topics: Adult; Drug Evaluation; Drug Therapy, Combination; Heart Rate; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Penbutolol; Propanolamines | 1985 |
Penbutolol or hydrochlorothiazide once a day in hypertension. A controlled study with home measurements.
Topics: Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Humans; Hydrochlorothiazide; Hypertension; Middle Aged; Penbutolol; Propanolamines; Renin; Substance Withdrawal Syndrome | 1981 |
4 other study(ies) available for hydrochlorothiazide and penbutolol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
[Penbutolol and arterial hypertension].
Topics: Blood Pressure; Diabetes Complications; Dihydralazine; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hyperlipidemias; Hypertension; Hyperthyroidism; Male; Penbutolol; Propanolamines; Reserpine | 1987 |
[Clinical evaluation of penbutolol (Hoe 893d) (beta adrenergic blocker), alone and in combination with hydrochlorothiazide, in the treatment of arterial hypertension. II. Effect on plasma electrolytes, renal function, plasma renin and aldosterone activity
Topics: Aldosterone; Antihypertensive Agents; Drug Therapy, Combination; Electrolytes; Humans; Hydrochlorothiazide; Hypertension; Kidney Function Tests; Lipids; Penbutolol; Propanolamines; Renin; Risk | 1985 |